Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific AC018755.18 ENSG00000268500 19 51612091-51646889 Predicted membrane proteins Evidence at transcript level Evidence at transcript level HPA009085 Approved Group enriched 5 appendix: 7.3;bone marrow: 14.2;lymph node: 3.6;spleen: 5.0 urinary bladder: 1.4 APLNR AGTRL1, APJ, APJR, FLJ90771 ENSG00000134817 Apelin receptor 11 57233577-57237314 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025842 Approved Group enriched 5 cerebral cortex: 82.9;placenta: 145.6;spleen: 164.2 adipose tissue: 24.9 CCR9 CDw199, GPR-9-6, GPR28 ENSG00000173585 Chemokine (C-C motif) receptor 9 3 45886504-45903177 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB006839 Uncertain Group enriched 6 appendix: 1.5;duodenum: 3.9;small intestine: 5.8;spleen: 1.2 lymph node: 0.5 CEACAM4 CGM7 ENSG00000105352 Carcinoembryonic antigen-related cell adhesion molecule 4 19 41618971-41627074 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 appendix: 6.8;bone marrow: 14.0;spleen: 9.1 adipose tissue: 1.7 CETP BPIFF ENSG00000087237 Cholesteryl ester transfer protein, plasma 16 56961850-56983845 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 adipose tissue: 36.8;liver: 21.6;lymph node: 47.1;placenta: 50.0;spleen: 79.2 thyroid gland: 8.4 CPLX3 CPX-III ENSG00000213578 Complexin 3 15 74826547-74831802 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Group enriched 8 prostate: 127.7;spleen: 75.8 cerebral cortex: 12.9 CROCC2 ENSG00000226321 Ciliary rootlet coiled-coil, rootletin family member 2 2 240906330-240993311 Predicted intracellular proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level HPA048678 Uncertain Group enriched 5 fallopian tube: 8.6;spleen: 3.3 lung: 1.1 GPR88 ENSG00000181656 G protein-coupled receptor 88 1 100538137-100542018 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA007488 Uncertain Approved Group enriched 12 breast: 9.7;cerebral cortex: 3.1;liver: 5.1;ovary: 3.4;parathyroid gland: 7.9;spleen: 14.7 adipose tissue: 0.6 KCNT1 KCa4.1, KIAA1422, SLACK, Slo2.2 ENSG00000107147 Potassium channel, sodium activated subfamily T, member 1 9 135702185-135795508 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059880 Uncertain Group enriched 5 cerebral cortex: 11.7;ovary: 3.9;skeletal muscle: 3.9;spleen: 6.7 testis: 1.2 KLRC2 CD159c, NKG2-C ENSG00000205809 Killer cell lectin-like receptor subfamily C, member 2 12 10426854-10442300 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA058052 Approved Plasma membrane Group enriched 6 cerebral cortex: 17.4;spleen: 8.3 stomach: 2.0 LRTM1 HT017 ENSG00000144771 Leucine-rich repeats and transmembrane domains 1 3 54918237-54967088 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA013839 Uncertain Group enriched 5 esophagus: 4.3;skeletal muscle: 9.1;spleen: 9.0 prostate: 1.4 NKX2-5 CSX, CSX1, NKX2.5, NKX2E, NKX4-1 ENSG00000183072 NK2 homeobox 5 5 173232109-173235357 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065034 Approved Nucleoplasm
Cytosol Group enriched 130 heart muscle: 33.8;spleen: 14.8 breast: 0.1 NR5A1 AD4BP, ELP, FTZ1, FTZF1, SF-1 ENSG00000136931 Nuclear receptor subfamily 5, group A, member 1 9 124481236-124507430 Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 adrenal gland: 138.2;ovary: 36.3;spleen: 154.3 testis: 19.6 PF4 CXCL4, SCYB4 ENSG00000163737 Platelet factor 4 4 73981077-73982124 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026008, HPA052485 Supported Group enriched 5 bone marrow: 53.9;spleen: 13.7 placenta: 6.4 RP11-277P12.6 ENSG00000255641 12 10412312-10436001 Predicted membrane proteins Evidence at transcript level Evidence at transcript level HPA062570 Uncertain Group enriched 7 cerebral cortex: 8.2;spleen: 6.2 bone marrow: 1.0 SEPT4 ARTS, CE5B3, H5, hCDCREL-2, hucep-7, MART, PNUTL2 ENSG00000108387 Septin 4 17 58520250-58540818 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006855, HPA021587, HPA022905 Supported Supported Nucleoplasm Group enriched 5 adrenal gland: 218.2;cerebral cortex: 288.7;spleen: 57.8 adipose tissue: 36.8 SIGLEC11 ENSG00000161640 Sialic acid binding Ig-like lectin 11 19 49948985-49961172 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060278 Approved Group enriched 7 ovary: 79.9;spleen: 32.2 adrenal gland: 8.2 BANK1 BANK, FLJ20706 ENSG00000153064 B-cell scaffold protein with ankyrin repeats 1 4 101411286-102074812 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037002 Supported Approved Nucleoplasm
Plasma membrane
Cytosol Group enriched 5 appendix: 47.6;lymph node: 97.9;spleen: 78.5;thyroid gland: 21.5;tonsil: 90.9 urinary bladder: 13.3 BLK MGC10442 ENSG00000136573 BLK proto-oncogene, Src family tyrosine kinase 8 11494001-11564604 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005093 Approved Group enriched 10 appendix: 22.9;lymph node: 61.9;spleen: 41.3;tonsil: 54.0 urinary bladder: 4.5 BTLA BTLA1, CD272 ENSG00000186265 B and T lymphocyte associated 3 112463968-112499561 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047211, HPA062029 Supported Group enriched 7 appendix: 14.7;lymph node: 29.6;spleen: 14.8;tonsil: 25.7 urinary bladder: 3.1 CCR7 BLR2, CD197, CDw197, CMKBR7, EBI1 ENSG00000126353 Chemokine (C-C motif) receptor 7 17 40553769-40565472 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB003796, HPA031383, HPA074467 Supported Supported Mitochondria Group enriched 6 appendix: 91.9;lymph node: 98.3;spleen: 39.9;tonsil: 80.2 urinary bladder: 12.9 CD19 ENSG00000177455 CD19 molecule 16 28931939-28939346 CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016110 Supported Group enriched 11 appendix: 38.8;lymph node: 85.0;spleen: 48.2;tonsil: 70.8 urinary bladder: 5.7 CD72 CD72b, LYB2 ENSG00000137101 CD72 molecule 9 35609533-35646810 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB002505, HPA044658 Supported Approved Nucleus
Mitochondria Group enriched 8 appendix: 26.2;lymph node: 72.0;spleen: 65.9;tonsil: 44.3 urinary bladder: 6.2 CD79A IGA, MB-1 ENSG00000105369 CD79a molecule, immunoglobulin-associated alpha 19 41877120-41881372 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000019 Supported Group enriched 6 appendix: 275.4;lymph node: 522.9;spleen: 324.4;tonsil: 440.3 stomach: 62.7 CD79B B29, IGB ENSG00000007312 CD79b molecule, immunoglobulin-associated beta 17 63928740-63932354 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA009178, CAB009751 Approved Uncertain Nucleoplasm
Plasma membrane
Cytosol Group enriched 5 appendix: 94.7;lymph node: 315.6;spleen: 160.3;tonsil: 196.1 bone marrow: 36.2 CLEC17A FLJ45910 ENSG00000187912 C-type lectin domain family 17, member A 19 14583084-14611157 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 10 appendix: 17.3;lymph node: 30.8;spleen: 19.8;tonsil: 29.7 urinary bladder: 2.4 CNR2 CB2 ENSG00000188822 Cannabinoid receptor 2 (macrophage) 1 23870526-23913362 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB009719 Uncertain Group enriched 7 appendix: 3.2;lymph node: 8.8;spleen: 8.1;tonsil: 7.2 bone marrow: 1.0 CR2 CD21 ENSG00000117322 Complement component (3d/Epstein Barr virus) receptor 2 1 207454230-207489895 CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002659, HPA052942, HPA060715 Supported Group enriched 22 appendix: 70.8;lymph node: 207.6;spleen: 101.3;tonsil: 159.4 kidney: 6.1 CXCL13 ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13 ENSG00000156234 Chemokine (C-X-C motif) ligand 13 4 77511753-77611834 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052613 Uncertain Group enriched 7 appendix: 170.3;lymph node: 606.7;spleen: 430.3;tonsil: 411.9 urinary bladder: 60.1 FAM129C BCNP1, FLJ39802 ENSG00000167483 Family with sequence similarity 129, member C 19 17523301-17553839 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043277 Approved Group enriched 15 appendix: 14.5;bone marrow: 11.3;lymph node: 28.5;spleen: 37.6;tonsil: 9.7 gallbladder: 1.3 FAM178B LOC51252 ENSG00000168754 Family with sequence similarity 178, member B 2 96875882-96986592 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042516, HPA062110 Uncertain Uncertain Nuclear speckles
Golgi apparatus Group enriched 5 bone marrow: 11.4;epididymis: 6.6;spleen: 17.0;testis: 7.4 fallopian tube: 2.0 FCER2 CD23, CD23A, CLEC4J, FCE2 ENSG00000104921 Fc fragment of IgE, low affinity II, receptor for (CD23) 19 7688758-7702146 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002624, HPA008928 Approved Group enriched 7 appendix: 22.9;lymph node: 48.1;spleen: 53.7;tonsil: 39.4 adipose tissue: 5.7 FCRL2 CD307b, FCRH2, IRTA4, SPAP1 ENSG00000132704 Fc receptor-like 2 1 157745733-157777132 CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 appendix: 16.9;lymph node: 28.7;spleen: 26.3;tonsil: 24.6 rectum: 3.1 FCRL3 CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e ENSG00000160856 Fc receptor-like 3 1 157674321-157700857 CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA015508 Approved Group enriched 12 appendix: 18.8;lymph node: 56.6;spleen: 37.3;tonsil: 33.6 urinary bladder: 2.9 FCRLA FCRL, FCRLa, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FCRLM1, FCRLX, FREB, MGC4595 ENSG00000132185 Fc receptor-like A 1 161706972-161714352 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016545 Supported Group enriched 10 appendix: 32.5;lymph node: 81.6;spleen: 57.4;tonsil: 90.1 urinary bladder: 6.5 HLA-DOB ENSG00000241106 Major histocompatibility complex, class II, DO beta 6 32812763-32817048 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013846 Approved Group enriched 5 lymph node: 19.9;spleen: 18.8;tonsil: 31.8;urinary bladder: 8.6 colon: 3.6 IL24 C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16 ENSG00000162892 Interleukin 24 1 206897443-206904139 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB025972 Uncertain Group enriched 5 appendix: 17.9;lymph node: 37.6;spleen: 30.0;tonsil: 28.5 urinary bladder: 5.6 LILRB3 CD85a, HL9, ILT5, LIR-3, LIR3 ENSG00000204577 Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 19 54216278-54223506 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 6 adipose tissue: 5.3;appendix: 10.4;bone marrow: 8.3;lung: 8.7;spleen: 9.4;urinary bladder: 6.9 placenta: 1.3 LIMD2 MGC10986 ENSG00000136490 LIM domain containing 2 17 63695902-63701172 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062867 Approved Vesicles Group enriched 5 appendix: 145.1;bone marrow: 71.3;lymph node: 259.7;spleen: 195.3;tonsil: 145.7 urinary bladder: 31.4 LTB p33, TNFC, TNFSF3 ENSG00000227507 Lymphotoxin beta (TNF superfamily, member 3) 6 31580525-31582522 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA048884 Approved Approved Centrosome Group enriched 8 appendix: 19.4;lymph node: 22.5;spleen: 26.4;tonsil: 10.6 bone marrow: 2.6 MCF2L2 ARHGEF22, KIAA0861 ENSG00000053524 MCF.2 cell line derived transforming sequence-like 2 3 183178043-183428778 Disease related genes, Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA038946, HPA038947 Uncertain Approved Plasma membrane
Cytosol Group enriched 8 adrenal gland: 10.3;cerebral cortex: 17.1;parathyroid gland: 7.4;spleen: 3.5;testis: 4.6 prostate: 1.0 MS4A1 B1, Bp35, CD20, MS4A2 ENSG00000156738 Membrane-spanning 4-domains, subfamily A, member 1 11 60455752-60470760 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000015, HPA014341, HPA014391 Supported Group enriched 15 appendix: 249.3;lymph node: 780.6;spleen: 476.2;tonsil: 821.5 urinary bladder: 39.8 NPAS1 bHLHe11, MOP5, PASD5 ENSG00000130751 Neuronal PAS domain protein 1 19 47019820-47045775 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043364, HPA072259 Approved Approved Nucleoplasm Group enriched 5 cerebral cortex: 3.9;skin: 4.4;spleen: 1.9;stomach: 2.7 lymph node: 0.6 OTOA CT108, DFNB22 ENSG00000155719 Otoancorin 16 21678514-21760729 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041405 Uncertain Group enriched 14 spleen: 2.7;testis: 6.2 epididymis: 0.3 P2RX5 LRH-1, P2X5 ENSG00000083454 Purinergic receptor P2X, ligand gated ion channel, 5 17 3672199-3696404 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA021948, HPA067827 Supported Supported Cytosol Group enriched 10 appendix: 42.6;lymph node: 90.9;spleen: 75.5;tonsil: 48.4 bone marrow: 6.2 POU2F2 OCT2, OTF2 ENSG00000028277 POU class 2 homeobox 2 19 42086110-42196585 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002513, HPA040368, HPA062096, HPA064404 Supported Supported Nucleoplasm Group enriched 6 appendix: 37.8;lymph node: 62.5;spleen: 37.2;tonsil: 45.5 urinary bladder: 8.1 SEMA3D coll-2, Sema-Z2 ENSG00000153993 Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D 7 84995553-85186855 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA037522 Uncertain Approved Golgi apparatus
Plasma membrane Group enriched 5 spleen: 67.1;thyroid gland: 76.0 prostate: 13.5 SIT1 SIT ENSG00000137078 Signaling threshold regulating transmembrane adaptor 1 9 35649295-35650950 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018506 Supported Group enriched 5 appendix: 25.6;lymph node: 56.9;spleen: 22.3;tonsil: 30.9 urinary bladder: 6.3 SP140 LYSP100-A, LYSP100-B ENSG00000079263 SP140 nuclear body protein 2 230203110-230313215 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006162, HPA067493 Supported Approved Nucleoli fibrillar center
Mitochondria Group enriched 6 appendix: 34.0;lymph node: 65.2;spleen: 38.9;tonsil: 52.9 urinary bladder: 7.9 STAP1 BRDG1, STAP-1 ENSG00000035720 Signal transducing adaptor family member 1 4 67558728-67607337 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038529 Supported Uncertain Nucleoplasm
Vesicles Group enriched 6 appendix: 24.7;kidney: 13.1;lymph node: 60.3;spleen: 27.0;tonsil: 58.9 testis: 6.1 TLR10 CD290 ENSG00000174123 Toll-like receptor 10 4 38772239-38782990 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 7 appendix: 22.0;lymph node: 52.3;spleen: 35.2;tonsil: 46.8 urinary bladder: 5.7 TMEM156 FLJ23235 ENSG00000121895 Transmembrane protein 156 4 38966744-39032922 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 6 appendix: 12.2;lymph node: 28.1;spleen: 15.4;tonsil: 25.3;urinary bladder: 5.9 gallbladder: 3.1 TNFRSF13C BAFFR, CD268 ENSG00000159958 Tumor necrosis factor receptor superfamily, member 13C 22 41922023-41926818 CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA003246, CAB008380 Supported Uncertain Nucleus Group enriched 10 appendix: 23.8;lymph node: 46.7;spleen: 44.4;tonsil: 51.9 bone marrow: 4.0 TUBB1 dJ543J19.4 ENSG00000101162 Tubulin, beta 1 class VI 20 59019254-59026654 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004286, HPA043640, HPA046280 Approved Supported Microtubules Group enriched 5 bone marrow: 4.8;lung: 1.9;placenta: 1.2;spleen: 5.3;testis: 1.5 gallbladder: 0.5